Operating Expenses

R&D

Dow R&D increased by 4.6% to $181.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.5%, from $200.00M to $181.00M. Over 4 years (FY 2021 to FY 2025), R&D shows a downward trend with a -3.2% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$228.00M$210.00M$225.00M$218.00M$217.00M$191.00M$225.00M$214.00M$205.00M$197.00M$213.00M$204.00M$196.00M$208.00M$202.00M$200.00M$188.00M$191.00M$173.00M$181.00M
QoQ Change-7.9%+7.1%-3.1%-0.5%-12.0%+17.8%-4.9%-4.2%-3.9%+8.1%-4.2%-3.9%+6.1%-2.9%-1.0%-6.0%+1.6%-9.4%+4.6%
YoY Change-4.8%-9.0%+0.0%-1.8%-5.5%+3.1%-5.3%-4.7%-4.4%+5.6%-5.2%-2.0%-4.1%-8.2%-14.4%-9.5%
Range$173.00M$228.00M
CAGR-4.7%
Avg YoY Growth-4.4%
Median YoY Growth-4.7%

Frequently Asked Questions

What is Dow's r&d?
Dow (DOW) reported r&d of $181.00M in Q1 2026.
How has Dow's r&d changed year-over-year?
Dow's r&d decreased by 9.5% year-over-year, from $200.00M to $181.00M.
What is the long-term trend for Dow's r&d?
Over 4 years (2021 to 2025), Dow's r&d has grown at a -3.2% compound annual growth rate (CAGR), from $857.00M to $752.00M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.